Edgar Lomax Co. VA cut its position in MetLife, Inc. (NYSE:MET – Free Report) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 153,750 shares of the financial services provider’s stock after selling 2,935 shares during the quarter. Edgar Lomax Co. VA’s holdings in MetLife were worth $12,589,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of MET. CX Institutional grew its position in MetLife by 15.9% in the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock valued at $5,568,000 after acquiring an additional 9,337 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of MetLife by 109.2% in the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after purchasing an additional 4,606,748 shares during the period. Smartleaf Asset Management LLC grew its holdings in shares of MetLife by 27.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock valued at $1,116,000 after purchasing an additional 2,940 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in MetLife by 1.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock worth $63,559,000 after buying an additional 12,723 shares during the period. Finally, Kingswood Wealth Advisors LLC acquired a new stake in MetLife during the 4th quarter worth approximately $259,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Wall Street Analyst Weigh In
MET has been the subject of several research reports. JPMorgan Chase & Co. dropped their price target on shares of MetLife from $88.00 to $86.00 and set an “overweight” rating for the company in a research note on Wednesday, April 2nd. Wells Fargo & Company lowered their target price on MetLife from $97.00 to $91.00 and set an “overweight” rating for the company in a research note on Thursday, April 10th. Piper Sandler upped their price target on MetLife from $92.00 to $94.00 and gave the stock an “overweight” rating in a report on Wednesday, April 2nd. Barclays decreased their price objective on MetLife from $95.00 to $88.00 and set an “overweight” rating for the company in a research note on Friday, April 11th. Finally, Cowen restated a “buy” rating on shares of MetLife in a research note on Friday, March 7th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and an average target price of $92.46.
MetLife Trading Up 1.1 %
Shares of MetLife stock opened at $72.49 on Friday. The company has a fifty day simple moving average of $79.19 and a 200-day simple moving average of $82.12. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a market cap of $49.38 billion, a price-to-earnings ratio of 12.14, a PEG ratio of 0.65 and a beta of 0.89.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Most active stocks: Dollar volume vs share volume
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.